ConductScience.org, home

Paper22869752

Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model.

Sanchez PE and 10 others. Proc Natl Acad Sci U S A, 2012. Cited by 541 papers, by iCite.

Cite this record

ConductScience Library. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model. Papers, record 22869752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22869752

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
2012
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
541
iCite
Relative citation ratio, by iCite
16.2
iCite
Revised in PubMed
2023-09-19
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sanchez PEPascal E
2Zhu LLei
3Verret LLaure
4Vossel KAKeith A
5Orr AGAnna G
6Cirrito JRJohn R
7Devidze NNino
8Ho KKaitlyn
9Yu GQGui-Qiu
10Palop JJJorge J
11Mucke LLennart

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
AnticonvulsantsMajor topic
CognitionMajor topic
Cognition DisordersMajor topic
Nerve NetMajor topic
PiracetamMajor topic
SynapsesMajor topic
Amyloid beta-Protein Precursor
Analysis of Variance
Animals
Blotting, Western
Electroencephalography
Humans
Immunohistochemistry
Levetiracetam
Maze Learning
Mice
Mice, Transgenic

Source PubMed

Download CSV of topics

Grants14

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P50 AG023501NIA NIH HHSUnited StatesP50AG023501PubMed and NIHNIH RePORTER
R01 AG011385NIA NIH HHSUnited StatesR01AG011385PubMed and NIHNIH RePORTER
K23 AG038357NIA NIH HHSUnited StatesK23AG038357PubMed and NIHNIH RePORTER
F32 AG039220NIA NIH HHSUnited StatesF32AG039220PubMedNIH RePORTER
AG011385NIA NIH HHSUnited StatesR01AG011385PubMed and NIHNIH RePORTER
AG022074NIA NIH HHSUnited StatesP01AG022074PubMed and NIHNIH RePORTER
P01 AG022074NIA NIH HHSUnited StatesP01AG022074PubMed and NIHNIH RePORTER
AG023501NIA NIH HHSUnited StatesP50AG023501PubMed and NIHNIH RePORTER
NS065780NINDS NIH HHSUnited StatesP30NS065780PubMed and NIHNIH RePORTER
RR18928-01NCRR NIH HHSUnited StatesPubMedPubMed
P30 NS065780NINDS NIH HHSUnited StatesP30NS065780PubMed and NIHNIH RePORTER
R37 AG011385NIA NIH HHSUnited StatesR01AG011385PubMed and NIHNIH RePORTER
C06 RR018928NCRR NIH HHSUnited StatesC06RR018928PubMed and NIHNIH RePORTER
R37AG011385NIHNIH RePORTER

Download CSV of grants

Trials4

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT02002819Levetiracetam for Alzheimer's Disease-Associated Network HyperexcitabilityBackgroundClinicalTrials.gov
NCT03461861Network-Level Mechanisms for Preclinical Alzheimer's Disease DevelopmentBackgroundClinicalTrials.gov
NCT03617497Prevalence of Epilepsy and Sleep Wake Disorders in Alzheimer DiseaseBackgroundClinicalTrials.gov
NCT04004702Levetiracetam for Alzheimer's Disease Neuropsychiatric Symptoms Related to Epilepsy Trial (LAPSE)BackgroundClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in23000687Neurodegenerative diseases: Anti-epileptic drug shows benefit in AD mouse model.https://conductscience.org/library/papers/23000687

Source PubMed

Download CSV of comments and corrections

References69

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115555635Effects of distinct classes of N-methyl-D-aspartate receptor antagonists on seizures, axonal sprouting and neuronal loss in vitro: suppression by NR2B-selective antagonists.Neuropharmacology2004https://conductscience.org/library/papers/15555635PubMed
219204149Epilepsy and cognitive impairments in Alzheimer disease.Arch Neurol2009https://conductscience.org/library/papers/19204149PubMed
320032967Treatment strategies targeting excess hippocampal activity benefit aged rats with cognitive impairment.Neuropsychopharmacology2010https://conductscience.org/library/papers/20032967PubMed
417785178Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease.Neuron2007https://conductscience.org/library/papers/17785178PubMed
521113149Reversing EphB2 depletion rescues cognitive functions in Alzheimer model.Nature2011https://conductscience.org/library/papers/21113149PubMed
619176798SV2 renders primed synaptic vesicles competent for Ca2+ -induced exocytosis.J Neurosci2009https://conductscience.org/library/papers/19176798PubMed
712576168Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy.Epilepsy Res2003https://conductscience.org/library/papers/12576168PubMed
810818140High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.J Neurosci2000https://conductscience.org/library/papers/10818140PubMed
921228179Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease.J Neurosci2011https://conductscience.org/library/papers/21228179PubMed
1019230774Calcium signaling and neurodegenerative diseases.Trends Mol Med2009https://conductscience.org/library/papers/19230774PubMed
117499323Levels and alternative splicing of amyloid beta protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease.J Biol Chem1995https://conductscience.org/library/papers/7499323PubMed
1219829367Neuroscience: Alzheimer's disease.Nature2009https://conductscience.org/library/papers/19829367PubMed
1321543591Soluble Aβ oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors.J Neurosci2011https://conductscience.org/library/papers/21543591PubMed
1417408599Effect of levetiracetam on molecular regulation of hippocampal glutamate and GABA transporters in rats with chronic seizures induced by amygdalar FeCl3 injection.Brain Res2007https://conductscience.org/library/papers/17408599PubMed
1516237174Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease.J Neurosci2005https://conductscience.org/library/papers/16237174PubMed
1621395360Levetiracetam: a review of its use in epilepsy.Drugs2011https://conductscience.org/library/papers/21395360PubMed
1720348922Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures.Nat Med2010https://conductscience.org/library/papers/20348922PubMed
1819935655Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses.Nat Neurosci2009https://conductscience.org/library/papers/19935655PubMed
199037091Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9037091PubMed
2018819729ß-amyloid-related peptides potentiate K+-evoked glutamate release from adult rat hippocampal slices.Neurobiol Aging2010https://conductscience.org/library/papers/18819729PubMed

See all 69 referencesDownload CSV of references

Cited by362

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 541 citations.

PMIDTitleJournalYearIn PapersSource
42951886Synaptic transmission and plasticity: molecular mechanisms, biological functions and therapeutic opportunities in neurodegenerative diseases.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42951886PubMed
42875809Levetiracetam restores GABAergic function and network homeostasis following Vps35 deficiency in excitatory neurons.Transl Neurodegener2026https://conductscience.org/library/papers/42875809PubMed
42818781Structural Determinants of Synaptic Vesicle Protein 2C Ligand Selectivity and Their Impact on Dopamine Release.bioRxiv2026https://conductscience.org/library/papers/42818781PubMed
42801635Co-activation of Selective Nicotinic Acetylcholine Receptor Subtypes Is Required for Neuroprotection against Alzheimer's Disease.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42801635PubMed
42344858Introducing the SAGE study: a multimodal protocol for testing a GABAergic mechanism of age-related episodic memory impairment across the sexes.BMJ Neurol Open2026https://conductscience.org/library/papers/42344858PubMed
42328935mTORC2-Nav1.2 signaling drives early hyperexcitability in Alzheimer's disease mouse model.Channels (Austin)2026https://conductscience.org/library/papers/42328935PubMed
42250220Impaired spatial coding and neuronal hyperactivity in the medial entorhinal cortex of aged APP knock-in mice.Cell Rep2026https://conductscience.org/library/papers/42250220PubMed
42146335Therapeutic targeting of fibrin-microglia interactions ameliorates Alzheimer's disease-related hyperexcitability and brain network dysfunction.bioRxiv2026https://conductscience.org/library/papers/42146335PubMed
42082835Lamotrigine Improves Spatial Learning and Attenuates AD-Related Pathology in APP/PS1 Mice, with Possible Involvement of the cAMP/PKA/CREB Pathway.Neurochem Res2026https://conductscience.org/library/papers/42082835PubMed
41987879Epilepsy and EEG abnormalities in neurodegenerative dementias: toward a system epilepsy framework.Front Aging Neurosci2026https://conductscience.org/library/papers/41987879PubMed
41933197Neuronal APOE4-induced early hippocampal network hyperexcitability in Alzheimer's disease pathogenesis.Nat Aging2026https://conductscience.org/library/papers/41933197PubMed
41906332Small Molecule Therapeutics Targeting Amyloid-β in Alzheimer's Disease: Mechanisms, Clinical Progress, and Future Strategies.Exp Neurobiol2026https://conductscience.org/library/papers/41906332PubMed
41871415Tau pathology in epilepsy: emerging mechanisms and translational opportunities.Brain2026https://conductscience.org/library/papers/41871415PubMed
41834887Myoclonus in geriatric dogs and its association with canine cognitive dysfunction: an online survey.Front Vet Sci2026https://conductscience.org/library/papers/41834887PubMed
41794826Selective weakening of population-coupled synaptic activity in vivo in a mouse model of amyloid-beta pathology.Nat Commun2026https://conductscience.org/library/papers/41794826PubMed
41766754Epilepsy and Alzheimer Disease: Epidemiologic, Clinical, Molecular, and Neuropathologic Convergences and Divergences.Neurol Clin Pract2026https://conductscience.org/library/papers/41766754PubMed
41743466ZCCHC17: a target for synaptic dysfunction and neuronal excitability in Alzheimer's disease.Front Aging Neurosci2026https://conductscience.org/library/papers/41743466PubMed
41735175Exploring Linalool-Based Phytotherapy for Excitatory/Inhibitory Imbalance in Alzheimer's Disease: A Review of Lavender and Cannabis Therapeutic Effects on Sleep, Seizures, and Cognition.Phytother Res2026https://conductscience.org/library/papers/41735175PubMed
41673049A physics-informed graph neural network to approximate docking-based binding affinity for DYRK2 in Alzheimer's drug repurposing.Sci Rep2026https://conductscience.org/library/papers/41673049PubMed
41671338Levetiracetam prevents Aβ production through SV2a-dependent modulation of APP processing in Alzheimer's disease models.Sci Transl Med2026https://conductscience.org/library/papers/41671338PubMed

See all 362 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
APP351PubTator's text mininghttps://conductscience.org/library/genes/351

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22869752

GET https://conductscience.org/api/papers/v1/22869752/references?page=2